Kymera Perspectives
Hear from our team on recent breakthroughs, scientific and clinical advancements, company culture, and our ongoing work to develop new medicines at Kymera.
February 12, 2025
A Revolution in Immunology: Creating New Possibilities with Oral Medicines
Kymera’s pioneering approach pushes boundaries to test new possibilities and has advanced drug candidates into the clinic that target the root causes of highly morbid—and often life-threatening— immuno-inflammatory conditions. Hear from Arsalan Shabbir, Vice President of Clinical Development, on how we’re working to build a future where patients have access to convenient and innovative therapies that can truly transform their lives.
Featured
October 28, 2024
STAT6 Degradation: A Paradigm Shift in Immunology
Nello Mainolfi, PhD, Founder, President & CEO
March 1, 2023
Living Our Core Values – Pioneer: Breaking new ground with a powerful new modality
Juliet Williams, PhD, Head of Research
April 21, 2023
Small Molecules, Big Impact: Expanding the Universe of Targets
Brian Albarran, PhD, Senior Vice President, Head of Corporate Strategy
Discover Our Latest Milestones
Stay ahead with the latest news from Kymera. Our Press Releases provide insights into our recent achievements and future endeavors.
Related Stories
